Legend Biotech (LEGN) Interest Expenses (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Interest Expenses data on file, last reported at $5.5 million in Q1 2026.

• Quarterly Interest Expenses rose 7.84% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.9 million (up 2.07% YoY) and the FY2025 annual result came in at -$21.4 million, down 199.01% from the prior year.
• Interest Expenses grew to $5.5 million in Q1 2026, from -$5.5 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $15.4 million in Q2 2023 to a low of -$26.3 million in Q3 2023.
• A 5-year average of -$1.9 million and a median of -$4.9 million in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses jumped 4043.81% — and 2024, when it plunged 89247.08%.
• Tracing LEGN's Interest Expenses over 5 years: stood at -$4.9 million in 2022, then surged by 99.88% to -$5820.0 in 2023, then sank by 89247.08% to -$5.2 million in 2024, then retreated by 5.77% to -$5.5 million in 2025, then surged by 200.0% to $5.5 million in 2026.
• The last three Interest Expenses figures came in at $5.5 million (Q1 2026), -$5.5 million (Q4 2025), and -$5.6 million (Q3 2025), per Business Quant data.